NO115207B - - Google Patents
Download PDFInfo
- Publication number
- NO115207B NO115207B NO15611164A NO15611164A NO115207B NO 115207 B NO115207 B NO 115207B NO 15611164 A NO15611164 A NO 15611164A NO 15611164 A NO15611164 A NO 15611164A NO 115207 B NO115207 B NO 115207B
- Authority
- NO
- Norway
- Prior art keywords
- insulin
- crystals
- crystallization
- size
- amount
- Prior art date
Links
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 claims description 116
- 239000013078 crystal Substances 0.000 claims description 71
- 102000004877 Insulin Human genes 0.000 claims description 58
- 108090001061 Insulin Proteins 0.000 claims description 58
- 229940125396 insulin Drugs 0.000 claims description 58
- 238000002425 crystallisation Methods 0.000 claims description 31
- 230000008025 crystallization Effects 0.000 claims description 30
- 238000000034 method Methods 0.000 claims description 14
- 239000002609 medium Substances 0.000 claims description 10
- 229910052751 metal Inorganic materials 0.000 claims description 10
- 239000002184 metal Substances 0.000 claims description 10
- 229910052736 halogen Inorganic materials 0.000 claims description 7
- 239000012736 aqueous medium Substances 0.000 claims description 6
- 230000002269 spontaneous effect Effects 0.000 claims description 6
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 210000004907 gland Anatomy 0.000 claims description 2
- 150000002367 halogens Chemical class 0.000 claims description 2
- 238000010899 nucleation Methods 0.000 claims 1
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Inorganic materials [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 29
- 239000000725 suspension Substances 0.000 description 17
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 16
- 239000011701 zinc Substances 0.000 description 11
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 8
- 235000005074 zinc chloride Nutrition 0.000 description 8
- 239000011592 zinc chloride Substances 0.000 description 8
- 238000002360 preparation method Methods 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 229910052725 zinc Inorganic materials 0.000 description 7
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 239000007853 buffer solution Substances 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- 239000007864 aqueous solution Substances 0.000 description 4
- -1 halogen ion Chemical class 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 239000007900 aqueous suspension Substances 0.000 description 3
- 210000000496 pancreas Anatomy 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000002035 prolonged effect Effects 0.000 description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 150000001342 alkaline earth metals Chemical class 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000012928 buffer substance Substances 0.000 description 1
- 229910052793 cadmium Inorganic materials 0.000 description 1
- BDOSMKKIYDKNTQ-UHFFFAOYSA-N cadmium atom Chemical compound [Cd] BDOSMKKIYDKNTQ-UHFFFAOYSA-N 0.000 description 1
- 230000007012 clinical effect Effects 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 229940102213 injectable suspension Drugs 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- 239000011572 manganese Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
Classifications
-
- D—TEXTILES; PAPER
- D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
- D06N—WALL, FLOOR, OR LIKE COVERING MATERIALS, e.g. LINOLEUM, OILCLOTH, ARTIFICIAL LEATHER, ROOFING FELT, CONSISTING OF A FIBROUS WEB COATED WITH A LAYER OF MACROMOLECULAR MATERIAL; FLEXIBLE SHEET MATERIAL NOT OTHERWISE PROVIDED FOR
- D06N3/00—Artificial leather, oilcloth or other material obtained by covering fibrous webs with macromolecular material, e.g. resins, rubber or derivatives thereof
- D06N3/12—Artificial leather, oilcloth or other material obtained by covering fibrous webs with macromolecular material, e.g. resins, rubber or derivatives thereof with macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. gelatine proteins
- D06N3/125—Artificial leather, oilcloth or other material obtained by covering fibrous webs with macromolecular material, e.g. resins, rubber or derivatives thereof with macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. gelatine proteins with polyamides
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dispersion Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Textile Engineering (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
- Coloring (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DEW0037805 | 1964-10-21 | ||
| DEW0035915 | 1965-10-19 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO115207B true NO115207B (xx) | 1968-09-02 |
Family
ID=26002641
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO15611164A NO115207B (xx) | 1964-10-21 | 1964-12-22 |
Country Status (5)
| Country | Link |
|---|---|
| BE (1) | BE657661A (xx) |
| CH (1) | CH477596A (xx) |
| GB (1) | GB1098874A (xx) |
| NL (1) | NL6415169A (xx) |
| NO (1) | NO115207B (xx) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5153991B2 (ja) * | 2004-02-26 | 2013-02-27 | 日本ゴア株式会社 | 防水透湿性複合フィルムおよび防水透湿性複合生地 |
-
1964
- 1964-11-25 CH CH1523864A patent/CH477596A/de not_active IP Right Cessation
- 1964-12-22 NO NO15611164A patent/NO115207B/no unknown
- 1964-12-28 BE BE657661A patent/BE657661A/xx unknown
- 1964-12-29 NL NL6415169A patent/NL6415169A/xx unknown
-
1965
- 1965-01-04 GB GB27565A patent/GB1098874A/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| NL6415169A (xx) | 1965-07-05 |
| GB1098874A (en) | 1968-01-10 |
| CH477596A (de) | 1969-08-31 |
| BE657661A (xx) | 1965-06-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Dietrich et al. | Comparison between ouabain and taurine effects on isolated rat and guinea-pig hearts in low calcium medium | |
| AU700545B2 (en) | Crystal of pyrrolidylthiocarbapenem derivative, lyophilized preparation containing said crystal, and process for producing the same | |
| NO166967B (no) | Anordning for opphengning av ruteenheter. | |
| US5304559A (en) | Compositions containing a 4-quinolone derivative complexed with a divalent metal ion | |
| NO174424B (no) | Fremgangsmaate for fremstilling av dinatrium-cefodizim | |
| CZ24389A3 (en) | Crystalline addition salts of 7-/alpha-(2-aminothiazol-4-yl)-alpha-(z)methoxyiminoacetamido/-3-/(1-methyl- -1-pyrrolidino)-methyl/-3-cephem-4-carboxylate, process of their preparation, and pharmaceutical compositions containing thereof | |
| US2920014A (en) | Insulin crystals and preparations and processes for producing them | |
| NO120906B (xx) | ||
| NO115002B (xx) | ||
| US2799622A (en) | Process of producing insulin crystals of substantially uniform size and compositions thereof | |
| NO115207B (xx) | ||
| US8258115B2 (en) | Stable salts of S-adenosylmethionine and process for the preparation thereof | |
| MX166069B (es) | Procedimiento para producir proinsulina humana cristalina | |
| EP4027977A1 (en) | Pharmaceutical composition of bimatoprost and timolol | |
| PT93580A (pt) | Processo de preparacao de composicoes fitossanitarias a base de ioes cobre e ciclodextrina e de tratamento fitossanitario | |
| US4504583A (en) | Process for crystallizing egg white lysozyme | |
| DE69517806T2 (de) | Stabile wässrige folinatlösung | |
| US3014842A (en) | Injectable bovine insulin crystal suspensions and process of producing same | |
| US3524798A (en) | Stabilization of alpha-amylase preparations | |
| US3058885A (en) | Process for treatment of insulin crystals and for production of insulin preparationstherefrom | |
| GB766995A (en) | Improvements in or relating to the production of insulin crystals | |
| US4150966A (en) | Method for cultivation of tobacco plants | |
| DE2527291A1 (de) | Acylderivate | |
| DK149347B (da) | Fremgangsmaade til fremstilling af insulinpraeparater med krystaller med 2-zn-struktur | |
| DE952208C (de) | Verfahren zur Herstellung von kristallinem Insulin |